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Abstract
Introduction
Each surgical procedure in ophthalmology is a subject of debate about its applications, ef  ciency, risk factors, 
contraindications, etc. There is, however, an indiscriminate and persistent consensus that post-operative in  am-
mation after each surgical intervention should be minimal. The incidence of in  ammation in the anterior chamber 
after cataract surgery may reach 30%, varying in severity. The anterior chamber in  ammatory response is sig-
ni  cant due to the fact that it can lead to elevated intraocular pressure (IOP), corneal edema, endothelial damage, 
 brinous exudation and membrane in the anterior chamber, posterior synechiae, cystoid macular edema, chronic 
anterior uveitis and others. Investigation and analysis of various factors in  uencing  brinous pre-chamber exu-
dation would pose new questions for discussion about the pre-, intra- and postoperative therapeutic algorithm.
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Aim
To investigate and analyze various factors that might be in correlation relationship with the development of 
 brinous reaction in the anterior chamber after phacoemulsi  cation surgery. Let’s also present our clinical expe-
rience in the treatment of acute  brinous exudation.
Material and methods
The design of the present clinical study is retrospective and observational, with tracked period 04.01-
15.12.2017. Criteria for inclusion in the study were standard phacoemulsi  cation of the lens without intraopera-
tive complications and implantation of IOL into the capsuler bag. The exclusion criteria taken into account for 
the purpose of differentiating the risk factors only for the phacoemulsi  cation as a surgical method are executing 
the one-step combined surgical procedure (phacoemulsi  cation with trabeculectomy, phacoemulsi  cation with 
pars plan vitrectomy). The preoperative set of studies performed includes a thorough ophthalmologic exam, 
indirect ophthalmoscopy, Goldmann tonometry, keratometry and biometric ultrasonic A echography. To all 191 
participants in the study, of which 67 men (35.1%) and 124 women (64.9%), with average age  68 years, by 
planned order was assigned a phacoemulsi  cation of the lens with implanted intraocular arti  cial lens (IOL). All 
operations were performed in the 3rd ward of the Ophthalmology Clinic, University Hospital “Aleksandrovska”, 
by one surgeon, according to the same methodology approved in the clinic.
Results
To all 191 patients (191 eyes) was accomplished phacoemulsi  cation of the lens and implanted an IOL, ac-
cording to a methodology approved in the ward without any complications. 78 (40.8%) of the participants had 
a hydrophobic, acrylic, aspheric implant, while the other group of 113 (59.2%) participants had a hydrophilic, 
acrylic, aspheric IOL. The patients with conventional monofocal (hydrophilic and hydrophobic) IOL were 162 
(84.8%) and 29 (15.2%) were with implanted hydrophilic IOL with extended depth of focus. Fibrinous exudation 
in the anterior chamber during the early postoperative period was found in  ve patients (2.4%) of the studied 
cohort. After local therapy with anti-in  ammatory drugs (corticosteroids), the  brinous membrane in each of the 
 ve patients is completely absorbed. It was reported that the presence of diabetes mellitus (80% of the patients 
with exudation) as an accompanying disease and the implantation of monofocal hydrophilic IOL (for 100% of 
patients with exudation) were the factors with the highest predictive value for developing a pathological  brin-
ous reaction.
Conclusion
Senile cataract is among the main age-related eye diseases. Its frequency increases as the age advances. In the 
national and world scale, phacoemulsi  cation is the most commonly performed surgical intervention in ophthal-
mology. The variety of intraocular arti  cial lenses nowadays is enormous, aiming to satisfy the ever-increasing 
demands and standards in ocular surgery. The rising incidence of diabetes mellitus poses new and important 
questions about which type of IOL are the most appropriate and recommended in patients with systemic accom-
panying diseases.
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възраст LOCS ВОН BCVA EPT Процедура ВОЛ power
Група
191 очи
68г. 2-3ст. 19mmHg 0,2 4,81s факоемулсификация 20,5D
LOCS – lens opacifi cation classifi cation system
EPT – eff ective phaco time
 1
       :
  
 -  ,  – 
     ;
 -   –   
  
 SPSS Statistics
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Група без фибрин 
(n=186)
Група с фибрин (n=5) p value
Възраст 67,5 70 0,468
Пол M/Ж 65/121 2/3 0,389
ЕРТ 4,5s. 9,6s. 0,113
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